← Leaderboards
Srilata Bagchi
University Of Illinois At Chicago
$1,639,516
Attributed
$2,420,187
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $325.8K · FY2010–20$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,420,187 · 3
By mechanism
R01$2,260,287 · 2
R03$159,900 · 1
Top collaborators
- Pradip Raychaudhuri5 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Ah-Ng Tony Kong$19,827,201
- Pradip Raychaudhuri$16,086,722
- Clifton David Fuller$6,957,707
- Marian L Fitzgibbon$23,506,286
- Gail S Prins$10,842,955
Others in their field
Top investigators on “Proteolysis”
- Alexander J Varshavsky · California Institute Of Technology$23,104,416
- Eric S. Orwoll · Oregon Health And Science University$20,906,524
- John S Condeelis · Yeshiva University$19,952,591
- Michele Pagano · New York University School Of Medicine$18,357,000
- Stephen C. Blacklow · Massachusetts Institute Of Technology$16,591,203
- Chih-Lueh Albert Wang · Boston Biomedical Research Institute$16,375,297
Research focus
ProteolysisMalignant NeoplasmsIn VivoUbiquitin-Protein LigaseResponseProteinsPlayMediatingRegulationSquamous Cell CarcinomaGenesExhibitsLinkCellsHead And Neck StructureDna DamageTumor Suppressor ProteinsAntioxidantsInduced MutationCatalaseGene Expression RegulationHomologous GeneInhibition Of ApoptosisBinding (Molecular Function)
Grant awards (10)
DDB2 is a regulator of HIF1A and EMT in HNSCC$79,950
R03 · FY2020 · CA · contact PI
DDB2 is a regulator of HIF1A and EMT in HNSCC$79,950
R03 · FY2019 · CA · contact PI
DNA Damage Response and DDB$306,522
R01 · FY2014 · CA
DNA Damage Response and DDB$297,042
R01 · FY2013 · CA
DNA Damage Response and DDB$316,002
R01 · FY2012 · CA
DNA Damage Response and DDB$316,002
R01 · FY2011 · CA
DNA Damage Response and DDB$325,775
R01 · FY2010 · CA
PAPILLOMAVIRUS ONCOGENES AND ORAL CANCER$239,901
R01 · FY2002 · DE
PAPILLOMAVIRUS ONCOGENES AND ORAL CANCER$232,914
R01 · FY2001 · DE
PAPILLOMAVIRUS ONCOGENES AND ORAL CANCER$226,129
R01 · FY2000 · DE